Decline of FEV1 by age and smoking status: facts, figures, and fallacies.

Assessment of pulmonary function testing plays as well as in patient based research and in epidemiological studies of healthy subjects, and a central role in everyday practice of the pultherefore the items discussed will be mainly monary physician. New patients are diagnosed centred around the FEV1. and graded in severity on the basis of results from these tests, and the course of the disease in previously diagnosed patients is judged with General course of FEV1 over time the help of lung function measurements. The There is still considerable debate over the shape use of pulmonary function tests for these purof lung function increase and decline during poses requires a concept of what constitutes life. During childhood and adolescence there both a normal level and a normal decline and, is naturally a rise in lung function, the exact consequently, an unusually low level and acshape of which is beyond the scope of this celerated decline. The concept of a normal paper. For the period early in adult life, differlevel is perceived to be fairly straightforward ent shapes have been suggested. Although some and is routinely deducted from some set of authors have taken the decline in lung function reference values. The population selection of to start at 15–20 years of age, 3 others have the reference equations used is taken to be found that the FEV1 continues to rise to the sufficiently representative of the patient under age of 25 years, or even into the fourth Department of study. In this review the problems associated Pulmonology decade. 7 It is probably fair to say that in with this assumption will be discussed and the and Department of healthy individuals there is a plateau phase in Epidemiology, cut off values between normal and abnormal early adulthood in which there is little or no University of examined. The same reference equations are change in FEV1. 6 8 The European Community Groningen, often employed for the judgement of normal Groningen, for Coal and Steel stipulates that no change The Netherlands decline, assuming that the coefficient for age occurs between the ages of 18 to 25 and an H A M Kerstjens adequately represents decline in individuals. age of 25 years should be entered into the B Rijcken This approach, however, can be rather inregression equation for this whole age range. J P Schouten D S Postma adequate and this will be reviewed. AdAfter this plateau FEV1 starts to decrease, with ditionally, special reference will be given to the newer studies that exclude smokers more Correspondence to: Dr H A M Kerstjens, estimating decline in smokers. Because of its carefully suggesting a later start in nonDepartment of Pulmonology, ease of measurement and its very good resmokers. It has long been thought that this University Hospital Groningen, producibility, the forced expiratory volume in ensuing decrease is linear — that is, that FEV1 PO Box 30001, one second (FEV1) is the most widely used and decreases by the same number of ml each year. 9700 RB Groningen, The Netherlands. quoted lung function test in clinical practice However, many authors have now shown that the decline accelerates with ageing. 7 10–12 As a result of these models of change in FEV1, at any given time in adulthood FEV1 is determined by three factors: (1) the maximally attained level of lung function during early adulthood; (2) the onset of decline of lung function or, alternatively, the duration of the plateau phase; and (3) the rate of decline of lung function (fig 1). In other words, from one low measurement of FEV1 in an adult it is impossible to determine whether the reduced lung function is due to not having achieved a high maximum during early adulthood, to having had a shortened plateau phase, to having an accelerated rate of decline, or to any combination of these. c

[1]  J. Ware,et al.  Overview of issues in the longitudinal analysis of respiratory data. , 1996, American journal of respiratory and critical care medicine.

[2]  D. Wypij Spline and smoothing approaches to fitting flexible models for the analysis of pulmonary function data. , 1996, American journal of respiratory and critical care medicine.

[3]  J. Samet,et al.  Longitudinal studies of active and passive smoking. , 1996, American journal of respiratory and critical care medicine.

[4]  D. Dockery,et al.  Longitudinal studies of air pollution effects on lung function. , 1996, American journal of respiratory and critical care medicine.

[5]  I. Tager,et al.  Interpretation of longitudinal studies. An overview. , 1996, American journal of respiratory and critical care medicine.

[6]  D. Postma,et al.  Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[7]  S. Weiss,et al.  Longitudinal analyses of airway responsiveness and pulmonary function decline. , 1996, American journal of respiratory and critical care medicine.

[8]  J. Britton,et al.  The relationship of childhood respiratory infection to growth and decline in lung function. , 1996, American Journal of Respiratory and Critical Care Medicine.

[9]  D. Dockery,et al.  Effects of cigarette smoking on lung function in adolescent boys and girls. , 1996, The New England journal of medicine.

[10]  D. Hendrick Occupational and chronic obstructive pulmonary disease (COPD) , 1996, Thorax.

[11]  J. Hankinson,et al.  Longitudinal and cross-sectional analyses of lung function in steelworkers. , 1996, American journal of respiratory and critical care medicine.

[12]  N. Künzli,et al.  Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. , 1996, Thorax.

[13]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[14]  P. Enright,et al.  Spirometry and maximal respiratory pressure references from healthy Minnesota 65- to 85-year-old women and men. , 1995, Chest.

[15]  I. Tager,et al.  Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. , 1995, American journal of respiratory and critical care medicine.

[16]  E. Gaustad When in the Course , 1995 .

[17]  A. Buist,et al.  Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. , 1995, American journal of respiratory and critical care medicine.

[18]  D. Dockery,et al.  Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study. , 1995, American journal of epidemiology.

[19]  J. Lefante,et al.  Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65. , 1995, American journal of respiratory and critical care medicine.

[20]  X. Xu,et al.  Exposure-response relationship between passive smoking and adult pulmonary function. , 1995, American journal of respiratory and critical care medicine.

[21]  J. Parker,et al.  Impact of using stated instead of measured height upon screening spirometry. , 1994, American journal of respiratory and critical care medicine.

[22]  P. Lange,et al.  Decline of lung function in adults with bronchial asthma. , 1994, American journal of respiratory and critical care medicine.

[23]  J. Schouten,et al.  Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. , 1994, The European respiratory journal.

[24]  D. Dockery,et al.  A longitudinal study of the effects of parental smoking on pulmonary function in children 6-18 years. , 1994, American journal of respiratory and critical care medicine.

[25]  G. Borsboom,et al.  Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. , 1994, American journal of respiratory and critical care medicine.

[26]  X. Xu,et al.  Gender difference in smoking effects on adult pulmonary function. , 1994, The European respiratory journal.

[27]  D. Dockery Percentile curves for evaluation of repeated measures of lung function. , 1993, Occupational medicine.

[28]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[29]  R. Kronmal,et al.  Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. , 1993, The American review of respiratory disease.

[30]  D. Postma,et al.  A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. , 1992, The New England journal of medicine.

[31]  D. Dockery,et al.  Longitudinal lung function decline in subjects with respiratory symptoms. , 1992, The American review of respiratory disease.

[32]  W. Seed,et al.  Reference values and prediction equations for normal lung function in a non-smoking white urban population. , 1991, Thorax.

[33]  M. Lebowitz,et al.  Smoking and symptom effects on the curves of lung function growth and decline. , 1991, The American review of respiratory disease.

[34]  T A Louis,et al.  Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. , 1990, American journal of epidemiology.

[35]  M. Lebowitz,et al.  Comparisons of spirometric reference values and the proportions of abnormal subjects among male smokers and those symptomatic in a community population. , 1990, The American review of respiratory disease.

[36]  P. Schnohr,et al.  Decline of the lung function related to the type of tobacco smoked and inhalation. , 1990, Thorax.

[37]  P. Schnohr,et al.  Effects of smoking and changes in smoking habits on the decline of FEV1. , 1989, The European respiratory journal.

[38]  G. O'Connor,et al.  The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[39]  F. Speizer,et al.  The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. , 1988, The American review of respiratory disease.

[40]  M. Miller,et al.  Predicted values: how should we use them? , 1988, Thorax.

[41]  G. Viegi,et al.  Prevalence of respiratory symptoms in an unpolluted area of northern Italy. , 1988, The European respiratory journal.

[42]  T. Louis,et al.  Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. , 1988, The American review of respiratory disease.

[43]  J. Bloom,et al.  The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. , 1987, The New England journal of medicine.

[44]  M. Lebowitz,et al.  Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. , 1987, The American review of respiratory disease.

[45]  A. Woolcock,et al.  Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.

[46]  D. Postma,et al.  Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. , 1986, The American review of respiratory disease.

[47]  M. Lebowitz,et al.  Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. , 1986, The American review of respiratory disease.

[48]  M. Becklake,et al.  Concepts of normality applied to the measurement of lung function. , 1986, The American journal of medicine.

[49]  C. Barter,et al.  Factors affecting the decline of ventilatory function in chronic bronchitis. , 1985, Thorax.

[50]  F. Speizer,et al.  Longitudinal study of the effects of maternal smoking on pulmonary function in children. , 1983, The New England journal of medicine.

[51]  M. Lebowitz,et al.  Changes in the normal maximal expiratory flow-volume curve with growth and aging. , 1983, The American review of respiratory disease.

[52]  F. Kauffmann,et al.  Adult passive smoking in the home environment: a risk factor for chronic airflow limitation. , 1983, American journal of epidemiology.

[53]  H. Weill,et al.  Noncomparability of longitudinally and cross-sectionally determined annual change in spirometry. , 2015, American Review of Respiratory Disease.

[54]  M. Tockman Predictable confusion. , 1982, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[55]  R. Bossé,et al.  Longitudinal effect of age and smoking cessation on pulmonary function. , 2015, The American review of respiratory disease.

[56]  P. Quanjer,et al.  Decreases in VC and FEV1 with time: indicators for effects of smoking and air pollution. , 1981, Bulletin europeen de physiopathologie respiratoire.

[57]  J. Morris,et al.  Spirometric "abnormality" in a normal male reference population: further analysis of the 1971 Oregon survey. , 1980, American journal of industrial medicine.

[58]  B. Culver,et al.  Variability in interpretation of pulmonary function tests. , 1979, Chest.

[59]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[60]  J. Morris,et al.  Spirometric standards for healthy nonsmoking adults. , 2015, The American review of respiratory disease.

[61]  K. Poirier A quantitative definition of obstructive lung disease. , 1968, The American journal of medicine.

[62]  B. J. Sobol Some cautions in the use of routine spirometry. , 1966, Archives of internal medicine.

[63]  B. J. Sobol,et al.  Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility1 , 2022 .